Newsletter
Court allows cannabis rescheduling to proceed (Newsletter: September 10, 2026)
Feds issue warning about traveling with marijuana; Mike Tyson thanks Trump for cannabis clemency; MA sales hit $10 billion; Cannabis safety op-ed
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
*Rattling the tip jar* Got a few dollars you can spare to help Marijuana Moment pay our writers, keep our website running and grow into the kind of robust news organization the fast-paced world of drug policy deserves?
Join us for $25/month and be a part of our work: https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
The U.S. Court of Appeals for the District of Columbia Circuit rejected a request to block the Trump administration’s marijuana rescheduling move that was filed by a drug testing industry association and a pharmaceutical company.
- The court also rejected a request from two medical marijuana companies that had filed a motion to intervene in the rescheduling lawsuit by joining the side of the government and opposing the litigation from prohibitionists.
The State Department’s Bureau of Consular Affairs is warning Americans against traveling overseas with marijuana or CBD—saying that “just because a cannabis, THC, or CBD product is legal in your home state does not mean you can take it abroad.”
The Massachusetts Cannabis Control Commission reported that recreational sales have now crossed the $10 billion mark—with the state’s top regulator telling Marijuana Moment that rolling back legalization, as is proposed by an initiative on the November ballot, could “eliminate thousands of jobs, hundreds of businesses and billions in tax revenue.”
Mike Tyson is thanking President Donald Trump for granting clemency to two federal cannabis prisoners last week, telling Marijuana Moment that “no one should lose decades of their life for nonviolent cannabis offenses” and that he hopes more will soon be freed.
- “I hope this is only the beginning for those still waiting to rebuild their lives.”
Americans for Safe Access’s Steph Sherer argues in a new Marijuana Moment op-ed that acknowledging safety issues surrounding cannabis “is not a concession to prohibition” but that “solving them is how we protect the future of cannabis access.”
- “Cannabis safety should not be a political weapon, and it should not be an uncomfortable subject cannabis communities avoid. It should be an area of research, innovation, collaboration, investment and competition.”
Michigan Republican gubernatorial candidate John James is raising money from the marijuana industry as he pledges to repeal a new cannabis wholesale tax—while Democratic contender Jocelyn Benson called it a “new and emerging issue” without taking a clear stance.
A Georgia senator who sponsored a bill to expand medical cannabis access explained why he agreed to a House amendment to allow patients to vape marijuana flower.
- “You’ve got different additives that are put in that oil to have it hit a certain percent, and the flower is grown and there’s nothing added to it.”
/ FEDERAL
The new director of the Food and Drug Administration’s Center for Drug Evaluation and Research previously worked at psychedelics company Usona Institute.
Rep. Maggie Goodlander (D-NH) and primary challenger Paige Beauchemin, currently a state representative, spoke about their support for federal marijuana legalization during a debate.
/ STATES
Iowa Democratic gubernatorial candidate Rob Sand discussed his support for legalizing cannabis.
Vermont’s lieutenant governor is facing a $5,000 fine for allegedly growing at least 100 cannabis plants in a location where he did not have permission to do so.
A Massachusetts campaign working to pass a ballot initiative to roll back the state’s marijuana legalization law has raised more than $1.6 million this year, while the main opposition campaign has raised more than $1.5 million in the same period.
Pennsylvania’s auditor general published a report finding that the state’s medical cannabis program lacks proper internal controls to ensure inspections and enforcement actions were performed consistently and that it has inadequate approval processes for complaint conclusions and plans of corrections.
Virginia regulators posted draft marijuana rules.
Ohio regulators published standardized marijuana product label templates.
Oklahoma’s top medical cannabis regulator is pushing back against claims that the state’s business approval process is too slow and enforcement is too strict.
California regulators sent updates about various cannabis issues.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
/ INTERNATIONAL
Cayman Islands officials are reviewing public comments on potential changes to cannabis laws.
/ SCIENCE & HEALTH
A study found that “co-administered CBD increases the plasma availability of THC and its active metabolite 11-OH-THC.”
A study of rats found “relevant evidence supporting the therapeutic potential of CBG for cognitive impairments associated with schizophrenia.”
/ ADVOCACY, OPINION & ANALYSIS
Whitney Economics published a report on the hemp market.
/ BUSINESS
Shares in Curaleaf were reportedly purchased by the United Arab Emirates national security advisor.
Walmart is being sued for allegedly illegally firing an employee over a positive marijuana test.
Delaware retailers sold $5.6 million worth of legal marijuana products in July.
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.
Photo courtesy of Mike Latimer.
